Paclitaxel efficacy is increased by parthenolide via nuclear factor-kappaB pathways in in vitro and in vivo human non-small cell lung cancer models (Q43005287)
Jump to navigation
Jump to search
scientific article published in November 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Paclitaxel efficacy is increased by parthenolide via nuclear factor-kappaB pathways in in vitro and in vivo human non-small cell lung cancer models |
scientific article published in November 2010 |
Statements
1 reference
Paclitaxel efficacy is increased by parthenolide via nuclear factor-kappaB pathways in in vitro and in vivo human non-small cell lung cancer models (English)
1 reference
Gao ZW
1 reference
Zhang DL
1 reference
Guo CB
1 reference
1 November 2010
1 reference
1 reference
10
1 reference
7
1 reference
705-715
1 reference
Identifiers
1 reference
1 reference